FocusCELL THERAPY

Challenges for mesenchymal stromal cell therapies

See allHide authors and affiliations

Science Translational Medicine  20 Feb 2019:
Vol. 11, Issue 480, eaat2189
DOI: 10.1126/scitranslmed.aat2189

Article Information

vol. 11 no. 480

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication February 6, 2018
  • Resubmitted June 11, 2018
  • Accepted for publication January 9, 2019
  • .

Author Information

  1. Ivan Martin1,*,
  2. Jacques Galipeau2,
  3. Charles Kessler3,
  4. Katarina Le Blanc4 and
  5. Francesco Dazzi5
  1. 1Department of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
  2. 2Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI 53715, USA.
  3. 3Health Directorate, Directorate General for Research and Innovation, European Commission, 1049 Brussels, Belgium.
  4. 4Center for Hematology and Regenerative Medicine, Karolinska University Hospital, 171 77 Stockholm, Sweden.
  5. 5School of Cancer and Pharmacological Sciences, King’s Health Partners Cancer Research UK Centre, King’s College London, London SE1 9NH, UK.
  1. *Corresponding author. Email: ivan.martin{at}usb.ch

Altmetric

Article usage

Article usage: February 2019 to June 2020

AbstractFullPdf
Feb 20193216488315
Mar 2019399114124
Apr 20192547874
May 20192657256
Jun 20192394940
Jul 20191834028
Aug 20191572635
Sep 20191033523
Oct 20191572728
Nov 20191102729
Dec 20191312316
Jan 20201365247
Feb 20201202633
Mar 20201322628
Apr 20202153037
May 20201822022
Jun 20203446

Stay Connected to Science Translational Medicine